Clinical trials
Cardiovascular clinical trials
Below are recruiting cardiovascular clinical trials, each written for real people, not researchers. We’re tracking 1,178 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06826534Recruiting
At-home heart rehab for teens with heart failure risk
This study tests if a home-based exercise program using a Fitbit can help teens who had chemotherapy improve their heart and lung fitness. You would exercise at home, track your activity, and have monthly virtual check-ins for 6 months.
Los Angeles, CaliforniaAges birth–21 years - NCT05301192RecruitingEarly Phase 1
Study angiotensin-1-7 effects on hearts and blood vessels in older adults
This early-phase study tests how angiotensin-(1-7) affects blood vessels and the heart in people ages 65–80. It may help researchers understand how to improve cardiovascular function as we age.
Hershey, PennsylvaniaAges 65–80 - NCT05776082Recruiting
Study how healthy pregnancy heart risk affects outcomes
This study looks at how cardiovascular (heart and blood vessel) health during pregnancy is linked to pregnancy outcomes. It may help doctors better predict and improve outcomes by using information from routine prenatal care.
Hangzhou, ZhejiangAges 20–49 - NCT07211282Recruiting
Activity tracking for late-stage cardiac rehab
This trial uses a smartphone app to monitor and guide your physical activity during the final phase of cardiac rehab. It aims to help you safely stay active and improve your recovery.
Edegem, AntwerpAges 18 years+ - NCT06840756RecruitingPhase 4
Does donor-patient sex matching improve blood transfusion outcomes?
This trial tests whether giving ICU patients blood from a donor of the same sex (male-to-male or female-to-female) leads to better recovery compared to mismatched transfusions. The goal is to see if matching donor and patient sex makes a difference in how well patients do.
Hamilton, OntarioAges 18 years+ - NCT06804161RecruitingPhase 3
Testing SGLT2 Inhibitors for Heart Health in Hypertension
This trial tests whether an SGLT2 inhibitor (a type of diabetes drug) can help prevent heart attacks, strokes, and other heart problems in people with high blood pressure. You may be eligible if you are 60 or older, have high blood pressure, and have had a heart or blood vessel event (like a heart attack or stroke) or have certain risk factors (like smoking, high cholesterol, or obesity).
Lübeck, Schleswig-HolsteinAges 60 years+ - NCT07198789Recruiting
Low-sugar carbs for better fat and sugar levels
This study tests whether special carbohydrates that release sugar slowly (low glycemic index) can improve your blood fats (triglycerides) and other health markers better than regular whole grains. If you have moderately high triglycerides, this diet swap might help your metabolism and blood vessels.
Bologna, BOAges 18 years+ - NCT07093528Recruiting
CS Reducer study for heart failure with preserved pumping function
This trial is testing a device called CS Reducer to see if it can help people with a certain type of heart failure (HFpEF) and a problem with small blood vessels in the heart (CMD). The device may improve blood flow and reduce symptoms.
Rochester, MinnesotaAges 18 years+ - NCT06572943Recruiting
Moderate exercise during pregnancy and heart health
This study looks at whether doing moderate exercise during pregnancy is safe and helpful for both mom and baby's heart health. If you are in your first trimester and do not have any high-risk conditions, you might be able to join.
IoanninaAges 18 years+ - NCT06861153Recruiting
Study on eating more beans and lentils for heart health
This trial looks at whether eating more beans, lentils, chickpeas, and peas (called pulses) over 12 weeks can improve your heart and metabolic health. It is for people who currently eat less than 1.5 cups of these foods per week and are willing to add more to their diet.
Tucson, ArizonaAges 18–75 - NCT06862427Recruiting
Healthy lifestyle app for firefighters
This study tests a smartphone app that helps firefighters adopt healthier habits like better eating, exercise, and stress management. It aims to see if using the app can improve your overall health and well-being.
TaipeiAges 20 years+ - NCT06961630RecruitingEarly Phase 1
Heart protection after surgery
This trial tests if a personalized approach with blood thinners and statins can reduce heart risks after non-cardiac surgery. It is for adults 45 and older who had a heart injury during or after surgery.
New York, New YorkAges 45 years+ - NCT06877195Recruiting
Vein graft support mesh for bypass surgery
This trial tests a mesh wrap that supports the vein grafts used in bypass surgery. It may help those grafts stay open longer, especially for the right side of the heart.
Roma, RomaAges Any age - NCT03331380Recruiting
Low-energy MRI study for people with or without heart disease
This study tests a special MRI method that uses lower energy exposure. It aims to improve how well researchers can scan the heart and other organs while keeping the scan as safe and comfortable as possible.
Bethesda, MarylandAges 18–100 - NCT06724718Recruiting
Using a smartwatch to detect atrial fibrillation after chest surgery
This trial tests whether a smartwatch can detect atrial fibrillation in people who have had major chest surgery (like lung removal) within the last 48 hours. If successful, this could help catch heart rhythm problems early without extra hospital equipment.
AmiensAges 18 years+ - NCT06682221Enrolling by invitationPhase 3
Resistance training and supplement study for older adults
This study tests whether a resistance training program (like lifting weights) combined with a supplement can improve heart, lung, and metabolic health in older adults. The goal is to find ways to help seniors stay healthier and more active.
Anápolis, GoiásAges 60–85 - NCT06650488RecruitingPhase 4
Clopidogrel vs. Aspirin for Heart Protection in Blood Infection Patients
This trial tests whether switching from aspirin to clopidogrel better protects your heart and blood vessels during recovery from a serious staph infection in the blood. You may be eligible if you currently take aspirin for heart or stroke prevention.
Montreal, QuebecAges 18 years+ - NCT06806670Recruiting
Diet and exercise study for kidney transplant patients
This study tests whether a structured diet and exercise program can lower heart disease risk in kidney transplant recipients. If you've had a stable transplant for at least 6 months and up to 10 years, you may be able to join.
Bologna, BOAges 30–69 - NCT06784557RecruitingPhase 4
Study of ezetimibe's effect on gut bacteria
This trial tests whether ezetimibe, a cholesterol-lowering drug, changes the bacteria in your gut. It may help people with heart disease or high cholesterol who are already on a statin.
SeoulAges 19–80 - NCT06118281RecruitingPhase 3
Testing ziltivekimab after a heart attack
This study tests a new drug called ziltivekimab to see if it helps people who have recently had a heart attack. The drug is given as an injection and compared to a placebo (a shot with no active medicine).
Alexander City, AlabamaAges 18 years+ - NCT06731257Recruiting
Early discharge after a heart attack with home monitoring
This trial tests if people with a mild heart attack can go home early (within 48 hours) and be monitored virtually instead of staying in the hospital. It aims to make recovery more comfortable while ensuring safety.
LeedsAges 18–99 - NCT06686862RecruitingPhase 3
Anti-inflammatory drugs for acute myocarditis
This trial tests if non-steroidal anti-inflammatory drugs (NSAIDs), like ibuprofen, help people with acute myocarditis (inflammation of the heart muscle) who are hospitalized but have normal heart function. It aims to see if these drugs can reduce inflammation and improve recovery.
Majadahonda, MadridAges 18 years+ - NCT06517537Recruiting
Modified aortic root enlargement for small aortic valves
This trial tests a modified surgical technique for replacing a narrowed aortic valve in people whose valve opening is unusually small. The goal is to help the new valve fit better and work well.
Beijing, Beijing MunicipalityAges 50–70 - NCT06512571Recruiting
Heart changes in Fabry disease: an observational study
This study looks at people with Fabry disease, a genetic condition that can cause the heart muscle to thicken. Researchers want to understand how the heart's blood vessels change over time, which may help improve care for Fabry disease.
BeijingAges 18 years+
Hear when a new Cardiovascular trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiovascular?
- Yes. Clin2 currently lists 1,178 recruiting cardiovascular studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiovascular trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiovascular trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.